Mount Sinai wins $1.3 million NIH award to expand the New York City Virus Hunters program

The Icahn School of Medicine at Mount Sinai has received more than $1.3 million from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) to expand the New York City Virus Hunters program.

Coherus plans Humira biosimilar sale at 85% discount – Pharmaceutical Technology

Humira was AbbVie’s blockbuster drug with sales of $21.2bn in 2022. Credit: Coherus BioSciences. Coherus BioSciences has signed a US national distribution agreement with speciality

July 14, 2023

Halting pandemics at the source: The call for a proactive ‘One Health’ approach

The recent PLoS Pathogens review emphasizes proactively preventing pathogen spillover from animals to humans as a strategy against future pandemics, advocating for a holistic One

October 10, 2023

Black people still experience highest burden of air pollution-related deaths

Health benefits that have resulted from reductions in fine particulate air pollution aren’t distributed equally among populations in the U.S., a new Yale-led study finds.

September 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.